Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients-Reference-Cited by-同舟云学术

Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients

Published:2022-12-22 Issue: Volume: Page:
ISSN:0172-0643
Container-title:Pediatric Cardiology
language:en
Short-container-title:Pediatr Cardiol

Author:

Matsuo Osamu,Ishii Masanobu,Kaikita Koichi,Morinaga Jun,Miyamura Fumiya,Matsumoto Shiro,Tsujita Kenichi,Nakamura Kimitoshi

Funder

The research grant of The Morinaga Hoshikai

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00246-022-03076-8.pdf

Reference31 articles.

1. Van Den Helm S, Sparks CN, Ignjatovic V, Monagle P, Attard C (2022) Increased risk for thromboembolism after Fontan surgery: considerations for thromboprophylaxis. Front Pediatr 10:803408. https://doi.org/10.3389/fped.2022.803408

2. Firdouse M, Agarwal A, Chan AK, Mondal T (2014) Thrombosis and thromboembolic complications in Fontan patients: a literature review. Clin Appl Thromb Hemost 20:484–492. https://doi.org/10.1177/1076029613520464

3. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, NowakGöttl U, Vesely SK (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, ninth ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141:e737S-e801S. https://doi.org/10.1378/chest.11-2308

4. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR et al (2019) 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. Circulation 139:e698–e800. https://doi.org/10.1161/CIR.0000000000000603

5. Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B, Hughes M, Andrew M, Mccrindle BW (2011) Fontan anticoagulation study group, a multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 58:645–651. https://doi.org/10.1016/j.jacc.2011.01.061